Skip to main content

Allogeneic processed thymus tissue Side Effects

Applies to allogeneic processed thymus tissue: intramuscular implant.

Cardiovascular

Very common (10% or more): Hypertension (19%)[Ref]

Dermatologic

Very common (10% or more): Rash (15%)

Frequency not reported: Granuloma skin, urticaria[Ref]

Rash includes rash, granuloma skin, rash popular, urticaria.[Ref]

Gastrointestinal

Diarrhea includes diarrhea and hemorrhagic diarrhea.[Ref]

Common (1% to 10%): Diarrhea[Ref]

General

The most common adverse reactions reported were hypertension, cytokine release syndrome, rash, hypomagnesemia, renal impairment/failure, thrombocytopenia, and graft versus host disease.[Ref]

Hematologic

Very common (10% or more): Thrombocytopenia (12%)

Common (1% to 10%): Hemolytic anemia, neutropenia[Ref]

-Thrombocytopenia includes thrombocytopenia and immune thrombocytopenic purpura.

-Hemolytic anemia includes autoimmune hemolytic anemia, Coombs-positive hemolytic anemia, hemolysis, hemolytic anemia.[Ref]

Immunologic

Very common (10% or more): Cytokine release syndrome (18%), graft versus host disease (10%)[Ref]

Graft versus host disease (GVHD) includes GVHD, GVHD-gut, GVHD-skin, omenn syndrome.[Ref]

Metabolic

Very common (10% or more): Hypomagnesemia (16%)

Common (1% to 10%): Acidosis[Ref]

Acidosis includes acidosis and blood bicarbonate decreased.[Ref]

Nervous system

Common (1% to 10%): Seizure[Ref]

Seizures include infantile spasms, seizures, and febrile convulsion.[Ref]

Other

Common (1% to 10%): Pyrexia[Ref]

Renal

Very common (10% or more): Renal impairment/failure (12%)

Common (1% to 10%): Proteinuria

Frequency not reported: Acute kidney injury, blood creatinine increased, renal tubular acidosis[Ref]

Respiratory

Common (1% to 10%): Respiratory distress[Ref]

Respiratory distress includes respiratory distress, hypoxia, respiratory failure.[Ref]

More about allogeneic processed thymus tissue

Professional resources

Other brands

Rethymic

Related treatment guides

References

1. Product Information. Rethymic (allogeneic processed thymus tissue). Enzyvant Therapeutics Inc. 2021;1.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.